Astrocyte-derived glutathione attenuates hemin-induced apoptosis in cerebral microvascular cells

Glia. 2010 Nov 15;58(15):1858-70. doi: 10.1002/glia.21055.

Abstract

Intracerebral hemorrhage (ICH) induces neurovascular injury via poorly defined mechanisms. The aim of this study was to determine whether gliovascular communication may restrict hemorrhagic vascular injury. Hemin, a hemoglobin by-product, concentration- and time-dependently increased apoptotic cell death in mouse bEnd.3 cells and in primary human brain microvascular endothelial cells, at least in part, via a caspase-3 dependent pathway. Cell death was preceded by a NFκB-mediated increase in inflammatory gene expression, including upregulation of inducible nitric oxide synthase (iNOS) expression and activity. Functionally, inhibition of iNOS or the addition of a peroxynitrite decomposition catalyst reduced cell death. Interestingly, co-treatment with astrocyte-conditioned media (ACM) reversed hemin-induced NFκB activation, nitrotyrosine formation, and apoptotic cell death, at least in part, via the release of the endogenous antioxidant, reduced glutathione (GSH). Prior treatment of astrocytes with the GSH-depleting agent, DL-buthionine (S,R)-sulfoximine or direct addition of diethyl maleate, a thiol-depleting agent, to ACM reversed the observed protection. In contrast, neither exogenous GSH nor the GSH precursor, N-acetylcysteine, was protective in bEnd.3 cells. Together, these data support an important role for astrocyte-derived GSH in the maintenance of oxidative balance in the vasculature and suggest therapeutic targeting of the GSH system may reduce neurological injury following ICH.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcysteine / pharmacology
  • Amino Acid Chloromethyl Ketones / pharmacology
  • Animals
  • Antioxidants / pharmacology
  • Apoptosis / drug effects*
  • Ascorbic Acid / pharmacology
  • Astrocytes / chemistry*
  • Brain / cytology
  • Caspase 3 / metabolism
  • Cells, Cultured
  • Curcumin / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Glutathione / metabolism
  • Glutathione / pharmacology*
  • Hemin / pharmacology*
  • Humans
  • L-Lactate Dehydrogenase / metabolism
  • Mice
  • Microvessels / cytology*
  • Neuroprotective Agents / pharmacology
  • Nitric Oxide Synthase Type II / metabolism
  • Peroxynitrous Acid / pharmacology
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases / metabolism
  • Time Factors

Substances

  • Amino Acid Chloromethyl Ketones
  • Antioxidants
  • Enzyme Inhibitors
  • Neuroprotective Agents
  • benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
  • Peroxynitrous Acid
  • Hemin
  • L-Lactate Dehydrogenase
  • Nitric Oxide Synthase Type II
  • Parp1 protein, mouse
  • Poly (ADP-Ribose) Polymerase-1
  • Poly(ADP-ribose) Polymerases
  • Caspase 3
  • Glutathione
  • Curcumin
  • Ascorbic Acid
  • Acetylcysteine